BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Staging
3519 results:

  • 1. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 7. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
    Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
    Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Squamous cell carcinoma malignant transformation in mature cystic teratoma of the ovary: a case report and review of the literature.
    Jafari-Nozad AM; Jahani N; Nazeri N
    J Med Case Rep; 2024 Mar; 18(1):145. PubMed ID: 38523295
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
    Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LncRNAs associated with lymph node metastasis in thyroid cancer based on TCGA database.
    Liu R; Liu W; Xue J; Jiang B; Wei Y; Yin Y; Li P
    Pathol Res Pract; 2024 Apr; 256():155255. PubMed ID: 38492360
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark.
    Spore LM; Dencker EE; Kvanner EA; Hansen CP; Burgdorf SK; Krohn PS; Kollbeck SLG; Storkholm JH; Sillesen M
    BMC Surg; 2024 Mar; 24(1):76. PubMed ID: 38431571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Discrepancies in staging and perioperative classification of pelvic endometriosis according to #Enzian 2021.
    Križanová K; Chvátal R; Križan V; Shibaeva M; Hudeček R
    Ceska Gynekol; 2024; 89(1):16-21. PubMed ID: 38418248
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
    Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
    BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Macroscopy of specimens from the genitourinary system.
    Varma M; Dormer J
    J Clin Pathol; 2024 Feb; 77(3):177-183. PubMed ID: 38373783
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma.
    Jannello LMI; Morra S; Scheipner L; Baudo A; Siech C; de Angelis M; Touma N; Tian Z; Goyal JA; Luzzago S; Mistretta FA; Piccinelli ML; Saad F; Chun FKH; Briganti A; Ahyai S; Carmignani L; Longo N; de Cobelli O; Musi G; Karakiewicz PI
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38363202
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of endocrine Surgery) multicentre study based on the EUROCRINE® national data.
    Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 176.